The Sage Group is at JPM/BIO Partnering in San Francisco from 13-16 January, 2025! Please click here to setup a meeting!

Ischemix is a privately-held US company developing a novel cytoprotective drug, CMX-2043, for the treatment of acute moderate-to-severe...